Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year

Reports Q4 revenue $24K vs. $41K last year. “We are pleased with our progress during the year and, more recently, with the results of our full PRIME study,” said CEO Zhenya Lindgardt. “We are also thankful to our investors for supporting our fundraise last month, which we believe will promote our mission to mitigate the societal and healthcare costs of spontaneous premature birth and afford better outcomes for moms and babies by helping us drive adoption of our technology.”